AIIMS Bhopal establishes HPMV Testing Facility amid Monkeypox concerns

In response to the growing threat of Monkeypox in India, AIIMS Bhopal has launched an HPMV (Hantavirus Pulmonary Syndrome and Monkeypox Virus) testing facility to enhance detection and treatment capabilities. This initiative aims to ensure prompt diagnosis and care for suspected cases while curbing the spread of the virus.

The facility includes an isolation unit designed to manage confirmed cases and prevent further transmission. The decision to establish this facility follows the detection of seven Monkeypox cases across India, prompting health authorities to ramp up measures to address the situation.

The newly established unit reflects preparedness to manage potential outbreaks. It is equipped to deliver high-quality care to patients and support containment efforts, demonstrating a proactive approach to managing public health risks.

Health officials have called for public vigilance and adherence to preventive measures. Monkeypox symptoms typically include fever, headache, muscle aches, swollen lymph nodes, and a rash. Early identification and isolation of symptomatic individuals are key to controlling the spread.

To mitigate risks, the public is urged to:

• Avoid close contact with individuals who are infected or showing symptoms.
• Wear protective gear, such as masks and gloves, especially in high-risk areas.
• Maintain good hygiene practices, including regular handwashing with soap.

The addition of this testing and treatment facility underscores AIIMS Bhopal’s commitment to safeguarding public health. Authorities are confident that these enhanced measures will significantly aid in containing the spread of Monkeypox within the region.

As India navigates this public health challenge, the focus remains on prevention, early detection, and effective management of cases. The establishment of such specialized facilities represents a crucial step toward minimizing the impact of the virus and protecting the broader population.